Transparency Market Research

In Vitro Diagnostics Market Is Growing at a CAGR of 7.1% from 2013 to 2019.

In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018

 
Repost This

Albany, NY -- (SBWIRE) -- 05/27/2014 -- In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) – Global Industry Analysis, Size, Share, Growth and Forecast, 2012 – 2018,” market was valued at USD 46.0 billion in 2011 and is expected to reach an estimated value of USD 74.2 billion in 2018, growing at a CAGR of 7.1% from 2012 to 2018.

Browse the full report athttp://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

In vitro diagnostics (IVDs) provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. Rising number of patients suffering from infectious and chronic diseases such as sexually transmitted diseases, chronic obstructive pulmonary disease, diabetes and cancer is the most significant growth driver of this market. In addition, factors such as increasing global healthcare expenditure and demand for rapid, minimally invasive and non-invasive diagnostic tools & techniques are driving the market as well.

In 2011, the North America IVD market held the second largest share of the global market at approximately 40%. The Asia-Pacific IVD market is expected to outperform all geographies in terms of growth rate during the forecast period. Presence of large patient pool and rising healthcare expenditure in these regions are responsible for this growth.

The clinical chemistry segment of the market held the largest market share across all major geographic regions such as the U.S., China and India in 2011. However, increase in demand for molecular diagnostics in the IVD market is expected to cut into the market share of clinical chemistry by 2018.

In 2011, Roche Diagnostics (Roche Group) held the largest share in the global in vitro diagnostics market followed by Siemens Healthcare (Siemens AG). Some of the other major companies involved in the development, manufacturing and distribution of in vitro diagnostics are Johnson & Johnson, Beckman Coulter Inc., Becton Dickinson and Company, Gen-Probe Incorporated and Thermo Fisher Scientific Corporation.

The global in vitro diagnostics market is categorized into the following segments:
- Market by Products

U.S.
- Clinical Chemistry
- Immunoassay
- Diabetes Testing
- Blood Testing
- Molecular Diagnostics
- Others (Flow Cytometry, Microbiological Diagnostic Techniques)

India
- Clinical Chemistry
- Immunoassay
- Diabetes Testing
- Blood Testing
- Molecular Diagnostics
- Others (Flow Cytometry, Microbiological Diagnostic Techniques)

China
- Clinical Chemistry
- Immunoassay
- Diabetes Testing
- Blood Testing
- Molecular Diagnostics
- Others (Flow Cytometry, Microbiological Diagnostic Techniques)

Market by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)

About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.